Home Tags Cancer Diagnosis

Cancer Diagnosis Related Content

acute myeloid leukaemia

Living with acute myeloid leukaemia (AML)

Bethany Torr, Campaigns and Advocacy Officer at Leukaemia Care explores the challenges of living with acute myeloid leukaemia (AML)
molecular signalling

TGF-β signalling – Tumor biology in prostate cancer

Identifying the molecular signalling pathways leading to advanced prostate cancer to improve therapy and diagnosis
cancer diagnosis

New data reveals cancer diagnosis could affect treatment options

Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.

Prostate cancer: Enigmatic, with different shades

Professor Ghulam Nabi from the University of Dundee explores the subject of the enigmatic prostate cancer, with different shades 
cancer diagnosis

Artificial Intelligence to improve cancer diagnosis

Ambitious new plans set out by the Prime Minister today will see around 22,000 fewer people dying from cancer each year by 2033
Prostate cancer

Prostate cancer treatment receives £75m funding boost

Prime Minister Theresa May has announced a further £75m in funding for “earlier and faster” diagnosis and treatment of prostate cancer, which kills more than 10,000 men each year
chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML): Leukaemia patients watching and worrying

Bethany Torr, campaigns and advocacy officer at Leukaemia Care discusses the impact of chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML) on patients
care in oncology

Need for supportive care in oncology will increase during the next decade

The need for supportive care in oncology will increase as patients continue to live longer and cancer progresses to become more like a chronic disease Supportive care increases patient quality of life, improves their chances of completing treatment, can reduce costs for healthcare institutions, and is fundamentally necessary given that...
Acute myeloid leukaemia

Acute myeloid leukaemia (AML) and cytarabine pharmacogenomics

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid leukaemia (AML) is the cancer of the myeloid precursor stem cells character­ised by the appearance of immature, abnormal myeloid cells in bone marrow and other...
burden of cancer

The global burden of cancer in young adults

Dr Miranda Fidler from the International Agency for Research on Cancer highlights the burden of cancer and the need for prevention, diagnosis, and care Cancer is a major cause of morbidity and mortality across all age groups in both developed and transitioning countries. Although substantial research on cancer in children...
cancer care

The challenge of sustainability in cancer care

All.Can shares their profound insights into the challenges concerning the need to improve the efficiency of cancer care, focusing on better outcomes for patients Healthcare budgets are under increasing pressure. We face an urgent question about how we can sustain high-quality healthcare. All.Can is an international multi-stakeholder initiative set up...

Lymphoma – what’s that?

Experts from the Lymphoma Association offer their thoughts on the extent of lymphoma in the UK today and how treatment and diagnosis can improve Every 28 minutes someone is diagnosed with lymphoma. It is the fifth most common cancer in the UK with more than 19,000 people diagnosed every year,...
early stage cancer

Early stage diagnosis – spotting early stage cancer events

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer

New developments in breast cancer treatment found

A mechanism used by breast cancer cells to grow and spread has been discovered. This has the potential to open the way for a new generation of treatments

Development of integrated non-invasive methods for cancer diagnosis and treatment

Stuart J. Corr1,2,3, Steven Curley1,4, Zhihui Wang5,6, and Vittorio Cristini5,6 1Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX 77030, USA 2Department of Chemistry, Rice University, Houston, TX 77005, USA 3Department of Bioengineering, University of Houston, Houston, TX 77004, USA 4Department of Mechanical Engineering and Materials Science, Rice University,...

Mathematical pathology in determining surgical volume for breast cancer treatment

Ductal carcinoma in situ (DCIS) is an early form of breast cancer that can be treated with surgery. Surgery can involve removal of the entire breast or partial removal of the tumour and the breast tissue surrounding it. In the case of partial removal, the challenge is knowing how...

Gynaecological cancers –prevention and early detection

Murat Gultekin, Vice-President of the European Society of Gynaecological Oncology (ESGO) highlights the importance of early detection of gynaecological cancers for prevention According to World Cancer Report 2014 (IARC), at least one third of cancers are preventable. This is true for gynaecological cancers, especially cervical cancer. However, less than 5%...
prostate cancer

The million dollar question in prostate cancer research

Owen Sharp, CEO at Prostate Cancer UK sheds light on the important work that’s being done to better diagnose and treat prostate cancer Most prostate cancers aren’t a problem. In fact, for many, the problems only come from diagnosing and treating them. These are the prostate cancers a surgeon once...

Cancer imperialism – how to diagnose bone metastases?

Cancer is an unreliable disease. Just as you think you are familiar with it and can begin treating and hopefully curing it, it is no longer as you thought it was. It has coloured its hair, carries other garments, or has changed its lifestyle making it unrecognisable and impossible...
Scientists develop blood test for bowel cancer

Scientists develop blood test for bowel cancer

A new blood test has been developed by scientists in Northern Ireland and the Irish Republic that can detect bowel cancer. The research, which is being conducted by Randox Laboratories and scientists at Dublin City University (DCU), can detect bowel cancer in its earliest stages and is more accurate than...

Follow Open Access Government